fatnews.com Home page  >  Article | Previous article | Next article

SEARCH

QUICKLINKS AND VIEW OPITONS

  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Follow @fatnews

    Qsymia (15 mg phentermine plus 92 mg topiramate) lost 8.9% more than with placebo


    Posted by .(JavaScript must be enabled to view this email address)
    Wednesday, July 18, 2012 3:40 pm Email this article

    Subjects given the higher doses of Qsymia (15 mg phentermine plus 92 mg topiramate extended-release) lost 8.9% of their body weight more than those given a placebo.

    Two studies lasting one-year with the drug

    Two studies lasting one-year with a total of 3700 people

    “The safety and efficacy of Qsymia were evaluated in two randomized, placebo-controlled trials that included approximately 3,700 obese and overweight patients with and without significant weight-related conditions treated for one year,” notes the FDA press release.

    “All patients received lifestyle modification that consisted of a reduced calorie diet and regular physical activity.”

    Reference

    FDA. FDA approves weight-management drug Qsymia. July 17, 2012.
    http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312468.htm

    More Info

    More info about Qsymia here

    Drug companies website:

    Other Articles

    Other articles about Qsymia (formerly Qnexa)

    Articles on the same subject can be found here:


    COMMENTS

    Please feel free to share your comments about this article.


    Name:

    Email:

    Comments:

    Please enter the word you see in the image below:


    Remember my personal information

    Notify me of follow-up comments?



    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.